semaglutide mechanism Insights into cardiovascular research: Mechanisms, trials, and frontiers This work not only highlights

Clinical evidence shows that GLP-1 activation produces lasting metabolic changes: users maintain weight loss longer after stopping therapy than with older diet drugs, and many experience improved blood pressure and cholesterol without additional medications

Multiple studies have demonstrated that water fasting for up to 21 days is well-tolerated, but none focused on patients with severe obesity (body mass index 40) or utilized treatment with glucagon-like peptide-1 receptor agonists (GLP-1)

People with diabetes who rely on insulin timing to match food absorption often face erratic blood sugar levels as food is absorbed at an unpredictable rate

10.1016/j.cmet.2015.04.008 103